Bioharvest Sciences (BHST) Cash from Investing Activities (2023 - 2025)
Bioharvest Sciences has reported Cash from Investing Activities over the past 3 years, most recently at -$668000.0 for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 67.0% year-over-year to -$668000.0; the TTM value through Dec 2025 reached -$2.4 million, up 21.87%, while the annual FY2025 figure was -$2.4 million, 21.87% up from the prior year.
- Cash from Investing Activities was -$668000.0 for Q4 2025 at Bioharvest Sciences, down from -$425000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$222000.0 in Q1 2024 and bottomed at -$1.9 million in Q2 2024.
- The 3-year median for Cash from Investing Activities is -$456000.0 (2023), against an average of -$612300.0.
- The widest YoY moves for Cash from Investing Activities: up 69.37% in 2025, down 206.31% in 2025.
- Over 3 years, Cash from Investing Activities stood at -$291000.0 in 2023, then tumbled by 37.46% to -$400000.0 in 2024, then plummeted by 67.0% to -$668000.0 in 2025.
- The last three reported values for Cash from Investing Activities were -$668000.0 (Q4 2025), -$425000.0 (Q3 2025), and -$592000.0 (Q2 2025) per Business Quant data.